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Abstract
Background: Uganda was the first country to scale up Home Based Management of Fever/Malaria
(HBM) in 2002. Under HBM pre-packaged unit doses with a combination Sulphadoxine/
Pyrimethamin (SP) and Chloroquine (CQ) called "HOMAPAK" are administered to all febrile
children by community selected voluntary drug distributors (DDs). In this study, community
perceptions, health worker and drug provider opinions about the community based distribution of
HOMAPAK and its effect on the use of other antimalarials were assessed.
Methods: In 2004, four focus group discussions with mothers and 11 key informant interviews
with drug sellers, drug distributors and health workers were conducted in Kasese district, western
Uganda. This was complemented by three months of field observations.
Results:  Caretakers concurred that they were benefiting from the programme. However,
according to the information from the DDs and health workers, many caretakers perceived
HOMAPAK as a drug of lower quality only meant for first aid. Caretakers also expressed need for
other drugs to treat other childhood diseases. The introduction of HOMAPAKs was said not to
affect the sale of other allopathic antimalarial drugs in the community. DDs expressed concerns
about lack of incentives and facilitation such as torches, gumboots and diagnostic equipment to
improve their performance.
Conclusion: HBM is well appreciated by the community. However, more efforts are needed to
improve uptake of the strategy through systematic community sensitization and community
dialogue. This study highlights the potential of community based volunteers if well trained,
facilitated and integrated into a functioning local health system.
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Background
In 2000, the African heads of states committed themselves
to the 'Abuja targets' of increasing the number of children
with malaria receiving timely and appropriate treatment
to 60% [1]. Experimental studies on Home Management
of Malaria (HMM) have reduced child mortality and mor-
bidity [2,3]. HMM is now being scaled up in sub-Saharan
Africa for prompt access to appropriate dosages within 24
hours of symptom onset [4,5]. Uganda was the first coun-
try to adopt HMM and scale it up on a national level as the
"Home Based Management of fever strategy" (HBM) [4].
Pre-packaged unit doses of a combination of sulphadox-
ine/pyrimethamine (SP) and chloroquine (CQ) under the
name "HOMAPAK" are distributed to caretakers with
febrile children by volunteer community based drug dis-
tributors (DDs). At the time of the study first line treat-
ment in Uganda had just changed from CQ alone to a
combination of SP and CQ, and HBM was used as a vehi-
cle to disseminate the new first line treatment.
Starting in 2002, HBM was first pilot tested in 10 districts
and by the end of 2003 there was a nation-wide scale up.
Prior to introduction of HBM, the community effective-
ness (CE) of malaria treatment, i.e. the cumulative pro-
portion of fever cases treated promptly with a
recommended antimalarial drug using correct dosing and
duration, had been shown to be less than 10% [6]. A fol-
low-up evaluation 18 months into the HBM intervention
indicated that 25% of febrile children used HOMAPAK
[7]. Although this is a considerable improvement it is still
far from the Abuja target set for 2005 of 60% of children
with fever receiving appropriate treatment within 24 of
symptom onset. While pre-HBM studies identified the
lack of attention to local fever illness perceptions as a
potential barrier to uptake and utilization of HBM [8],
post-implementation studies on communities' and health
workers' perceptions of the HBM strategy remain
unknown. Few studies have studied the formation and
implementation of new malaria treatment policies [9,10],
and none has so far explored how the policy of commu-
nity based antimalarial drug distribution diffused into the
community.
The aim of this paper was to explore community percep-
tions, health worker and drug provider opinions of com-
munity based distribution of pre-packed antimalarials
(HOMAPAK) and its effect on management of fever and
use of other antimalarials.
Methods
Study area and population
Kasese is located in western Uganda at the foot of Rwen-
zori Mountains on the border of the Democratic Republic
of Congo. The people are mainly subsistence farmers of
the Bakonzo tribe (Kasese District, 2000). The district
population density is 220/km2 and 89% lives in rural
areas. Malaria is hyper-endemic and the under-five mor-
tality rate has been estimated at 170/1000 – mostly caused
by malaria and pneumonia [11]. The district has 3 hospi-
tals and 67 health centers scattered in the valleys below
the steep hills. 67% of the Kasese population live within 5
kms of a health centre [12]. Kasese was one of the pilot
districts for the HBM intervention and implementation
started in 2002. The study was conducted two years after
HBM implementation in Kanyatsi and Kitholu, the first
parishes to receive the HBM intervention.
Data collection
To explore people's perceptions, experiences, knowledge
and opinions about HBM and HOMAPAKs, focus group
discussions (FGDs) were viewed as the most appropriate
method [13]. Four homogenous FGDs were held with
purposively selected groups of young and old mothers
ranging between 6–12 per group as they were perceived to
have sufficient knowledge and experience on the issues we
wanted to address [13]. A skilled social scientist modera-
tor assisted by a note taker, both fluent in the local lan-
guage, managed the FGDs which lasted on average 45
minutes and were digitally recorded. A thematic guide was
used which included management and treatment prac-
tices of febrile under-fives, types of medicines used,
sources of care sought, perceptions about HOMAPAK effi-
cacy in fever management and opinions about HBM in
general.
While the FGDs focused on the perceptions and attitudes
about HBM and HOMAPAKs, 11 key informant (KIs)
interviews were also performed by two of the authors (XN,
JN) to obtain in-depth information on the malaria man-
agement situation in the area, the process and progress of
implementation, as well as the apparent achievements
and challenges faced. The KIs were purposively selected
based on their position in the community, their role in
implementation, or because of the special information
they possessed based on their involvement in childhood
fever management. KIs included three health workers
from the local health centre in Kanyatsi parish and from
Kagando hospital, where most caretakers in the study
community are usually referred when their children
become severely sick. KI interviews were also performed
with four drug sellers and four DDs who were identified
with the help of the local leaders.
Health workers provided information on the link between
the DDs and the health facilities, the kind of facilitation
they provided to the DDs, their experiences about health
seeking behavior for fever for the under fives after the
introduction of HOMAPAK, their opinions about the
strategy and their assessment of DDs performance. Drug
sellers from three villages located in the study parishesMalaria Journal 2007, 6:11 http://www.malariajournal.com/content/6/1/11
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were purposively selected based on their proximity to
drug distributors and having stocks of antimalarial drugs.
Drug sellers were asked to share experiences on the effect
that HOMAPAK introduction had had on their business
and their opinions on the HBM strategy. DDs were asked
to share their experiences, achievements and challenges in
the distribution of HOMAPAK. When the information
became repetitive for each of the categories, interviewee
recruitment stopped.
To complement FGD and KI interview findings, one of the
authors (KK) undertook daily field observations and
informal discussions for a 3 month period in 2004 and
spent much time in the homes of some DDs discussing
their situation and observing their activities. Rich infor-
mation was also yielded through prolonged transect walks
together with local community members. Peculiar, excit-
ing and everyday mundane activities were recorded in a
field diary [14].
Data analysis
The FGDs were tape recorded, transcribed and translated
into English by the FGD moderator. Data from other
sources were recorded manually in notebooks and field
diaries. Thereafter, the data was systematically coded and
analysed manually for content. Recurrent and emerging
themes were identified and organized into meaningful
categories and sub-categories [15]. Relevant quotations
were extracted and some have been presented verbatim.
For comprehensiveness, data from the different data col-
lection techniques was triangulated to validate and com-
plement the findings from each of the sources [16]. The
findings are presented using a thematic approach whereby
responses from different respondents are integrated under
the same theme.
Ethical clearance
The study was approved by the Higher Degrees Research
and Ethics of Makerere Medical Faculty, Uganda and the
Regional Ethics Committee of the Karolinska Institutet,
Sweden (Dnr 02-373). Permission was obtained from the
district authorities and local leaders. There was informed
consent of the people who volunteered to participate in
the study.
Results
The main findings of the study were (1) communities had
not received sufficient information to enable them to
understand the rationale of home based management of
fever (2) the community's high appreciation of
HOMAPAK as the most accessible, free and prompt treat-
ment of hot body which has reduced the prevalence of
severe malaria among under fives (3) the perception of
HOMAPAK as a "light drug" of lower quality which can
not treat severe malaria and not matching with some chil-
dren's blood (4) the concern of focusing on one disease
instead of an integrated approach for managing multiple
conditions (5) the lack of community ownership and
facilitation of DDs as critical barriers to the sustainability
of the programme with motivated DDs.
In terms of preparation, a national communication strat-
egy [17] was developed but never fully implemented. As
per the HBMF implementation guideline [4], community
mobilization and sensitization was supposed to comple-
ment the activities to select and train DDs.
The DDs were given job-aids to explain to mothers how to
administer the drugs and when to go for referral. In prac-
tice only caregivers visiting the DDs received information
through face-to-face counselling. Similarly, the leaflets
with drug information enclosed in the HOMAPAK boxes
were only accessed by those who had already brought the
children to a DD for treatment. In addition a few posters
were displayed mainly in the clinics, and village sensitiza-
tion meetings were only held at the beginning during
selection of the DDs.
Respondents reported that HBM made a substantial con-
tribution to the management of malaria in the commu-
nity. Overall, caretakers in FGDs and KIs concurred that
provision of HOMAPAKs by DDs makes the drug easily
accessible, hence reducing treatment delays and risks of
development of severe malaria with convulsions.
"It [HOMAPAK] has helped in reducing ekikangararo (con-
vulsions). In the past, children would die a lot but now the rate
has reduced. We honor HOMAPAK" (FGD, old mothers).
Most caretakers during FGDs confidently argued that
HOMAPAK is effective if administered in time:
"In fact in this village we have mothers who do not like taking
their children early enough for treatmentthey even blame other
mothers who attend quickly to child's illness. It is always out of
negligence and carelessness. And for your information it is such
people who will preach that HOMAPAK does not work well on
children" (FGD, old mothers).
However, a few caretakers in FGDs remarked that
HOMAPAKs are not effective, especially when the malaria
is severe.
"HOMAPAKs can only be good when the child is not very sick.
You need strong drugs if malaria is high" (FGD, old mothers).
Both DDs and health workers agreed that some people in
the community perceived HOMAPAK as a weak drug and
only useful for non severe malaria. Some of the caretakersMalaria Journal 2007, 6:11 http://www.malariajournal.com/content/6/1/11
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who perceive HOMAPAK as weak drug may avoid going
to the drug distributor when their children have fever.
"You know people in our community think that drugs provided
in the community are very weak. They refer to them as 'omu-
batsi owahesi' meaning 'drugs of lower quality'. They believe
that the drugs provided in the clinics and drug shops are better"
(a DD).
Health workers and DDs also confirmed that community
members sometimes bypassed the DDs and sought treat-
ment directly from health facilities or drug shops where
they perceived the drugs to be 'stronger'. This was also
confirmed by the drug sellers who reported that the intro-
duction of HOMAPAKs had not affected their sales and
many people still prefer drugs from their shops:
"For me I have not seen how it has affected my business. People
still come to me because I have all the drugs they need like
panadol, aspirin and some antibiotics. There are some people
who come after failing with HOMAPAK and I give them qui-
nine. People prefer my drugs because I have sugar coated chlo-
roquine which most people prefer to the bitter one" (a drug
seller).
In addition, DDs and caretakers reported that there were
some children whose fever does not respond to
HOMAPAK treatment, which has led to mistrust of the
drug. While health workers were aware of the problem
with drug resistance, caretakers on the other hand attrib-
uted this to the mismatch between the child's blood and
HOMAPAK.
"The resistance to HOMAPAK nowadays is a common prob-
lem. When there is no effect for those who have used the drug,
they lose confidence and spread the rumours to others" (a
health worker).
"We did not go for HOMAPAK again because we suspected
that the blood of the child does not work with HOMAPAK or
there was another complication or probably the drug was not
effective" (a caretaker in clinic).
The community members were not satisfied with the fact
that HBM only brings one type of treatment and
demanded more drugs for the management of other
childhood illnesses.
"I would not suggest to change it but it [HOMAPAK] should
be accompanied with another pack containing cough tablets,
painkillers and those of flu" (FGD, young mothers).
DDs also confirmed that caretakers expected them to have
a variety of drugs to treat other childhood diseases in addi-
tion to malaria. In addition, both caretakers and DDs
expressed the need for antimalarial drugs for the adults
because if not treated, their malaria was believed to spill
over to the children.
"HOMAPAKs are unpopular because they do not provide them
for the old people. Only children are given the drugs and yet
sometimes the fever attacks the whole family at once. Instead of
going to the DDs, they will go to the drug shops where they will
get drugs for everyone" (a DD).
Both caretakers and DDs were concerned that HOMAPAK
was not being provided with Oral Rehydration Salt (ORS)
which, according to them, is essential for the management
of most of childhood illnesses. DDs acknowledged the
fact that caretakers had extensive knowledge about ORS
and considered it to be important also for fever manage-
ment. Reasons mentioned included that it restores water
in the body, gives the child strength, adds blood, reduces
the body temperature, stops the diarrhea, and supports
the other drugs the child is taking. They further argued
that ORS would be especially necessary in combination
with HOMAPAK which is perceived to dehydrate children.
"I use ORS for rehydration purposes. Also we want ORS
because Fansidar requires a lot of fluids. Also if the child is too
weak, he/she needs ORS and drinks. So we need ORS to be part
of the HOMAPAK. That is why mothers prefer going to
Kagando [Hospital] because in Kagando, they are given ORS
especially to a child who is vomiting and has diarrhea" (FGD,
old mothers).
"If the DDs were given ORS they would be more respected in
the community" (KI, community Leader).
Lack of facilitation of DDs was raised by different
respondents. Respondents maintained that DDs lacked
tools to make their work easier and both DDs and caretak-
ers agreed that diagnostic equipment would improve
diagnosis and hence attract more caretakers of febrile chil-
dren. Equipment such as thermometers and microscopes
were cited as critical.
"We need thermometers to check the level of temperature. Dur-
ing the training we were told that we should always establish
the temperature and when we find that it is too high we refer
the children to the health facility" (a DD).
Apart from diagnostic equipment, DDs said they needed
facilitation with lighting to enable them identify the
colored packs at night, gumboots to guard against snake
bites when visiting homes, soap to wash hands before
handling medicines and containers to keep medicine
safely. The concern about lack of DD facilitation was fre-
quently raised also by mothers.Malaria Journal 2007, 6:11 http://www.malariajournal.com/content/6/1/11
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"What happens is when you call him [DD] he comes and
checks your child and after another parent may call him in
another place. So if it is at night, these people [DDs] suffer in
the darkness and you know our place is hilly so they need lamps
and paraffin" (FGD, old mothers).
Moreover, DDs and caretakers were concerned about the
lack of remuneration and recognition by local govern-
ment authorities for the work performed. According to the
DDs' coordinator, the work load at the health centers
hampers health staff from interacting with and supervis-
ing the DDs in the community. This problem was also
confirmed during informal discussions with DDs and
community leaders who mentioned the lack of payment
and supervision as a great barrier to motivation.
"What makes somebody happy is the stomach. Although the
DDs may not be complaining directly, lack of allowances is
demotivating them. They will do their work at their own pace.
They cannot leave their gardens to attend the ailing children"
(Community Leader).
Discussion
This study highlights four key findings in relation to the
HBM strategy. First, in line with Kilian's predictions from
pre-HBM studies [18] HOMAPAK is highly appreciated in
the community as the most accessible, affordable and
prompt treatment of hot body. Second, although
HOMAPAK is popular, it is perceived as good only for
non-severe malaria and not "matching" with some chil-
dren's blood, especially if the treatment fails. Third, there
is concern about focusing on one disease instead of an
integrated approach for managing multiple conditions.
Fourth, lack of community ownership, facilitation and
incentives for DDs are critical barriers to a sustainable pro-
gramme with motivated DDs.
Perceptions of drug efficacy
The discussion about the mismatch between the child's
blood and the drug is a reflection of the emerging percep-
tions about the HOMAPAK innovation. The biomedical
view is that if the child does not improve after administra-
tion of HOMAPAK, the possible reasons for the treatment
failure could be caused by inappropriate dosing, drug
resistance, or that the cause of the fever may be another
disease than malaria. The caretakers view this failure dif-
ferently; they suspect either a mismatch between the drug
and the child's blood, or that HOMAPAK is a weak drug.
This implies that they may not give HOMAPAK again to a
child who did not respond to this treatment the first time
which may partly explain the 25% utilization-rate of
HOMAPAK for fever observed in a quantitative evaluation
study [7].
To understand community perception of efficacy these
issues have to be viewed in light of the cultural system
which provides a more satisfactory explanation of efficacy
than the biomedical view [19]. People's evaluation of effi-
cacy is based on experience and many expect highly effec-
tive drugs to make symptoms disappear immediately [20].
Having used a drug that worked is a strong reason as to
why the users selected the drug again [21]. A study in
Burkina Faso also showed that severity of disease and per-
ceived effectiveness of the treatment were the most impor-
tant determinants of low utilization of the community
health workers [22].
This implies that HOMPAKs will need to be updated to
contain drugs with high biological efficacy [23], to mini-
mize treatment failures. Furthermore, there is need to
understand and communicate on key community percep-
tions on the intervention as they emerge. For instance if
the child who has been given HOMAPAK does not
improve this may not be an "incompatibility with the
child's blood" but the illness could be caused by another
illness than malaria and that there is need for referral for
reassessment [24].
One disease versus integrated management approach
Whereas HBM stresses the importance of treating all fevers
as malaria, caretakers are aware that fever is a symptom of
several illnesses and often treat symptoms as separate dis-
eases with a variety of drugs [25,26]. Consequently, they
request a wider scope of treatments to be available from
the DDs. Furthermore, the large symptom overlap
between pneumonia and malaria also raises concern for
possible mistreatment and aggravation of a child with
pneumonia if treated with antimalarials alone [27].
Hence there is need to modify HBM to a more integrated
approach, addressing communities' own priorities while
still realizing that not every condition can be treated in the
community [28]. Providing ORS through the DDs seems
safe and is in line with the WHO/UNICEF recommenda-
tion to integrate community management of diarrhoea
and pneumonia in HBM strategies [29]. Integrating anti-
biotics for pneumonia and ORS for diarrhea in the com-
munity based management of childhood fevers would fit
both with community expectations and epidemiological
needs. The policymakers will benefit from additional evi-
dence from the African setting on the feasibility, cost and
effectiveness of integrating community management of
pneumonia and diarrhea into existing single disease man-
agement programmes such as Home Management of
Malaria [30].
Policy and community approach
HBM was designed to follow a systematic consultative and
participatory process involving different stakeholders at
the national, district and community levels [4]. However,Malaria Journal 2007, 6:11 http://www.malariajournal.com/content/6/1/11
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there has been limited time for consulting the commu-
nity, discussing their needs, understanding their percep-
tions and agreeing on the role they were supposed to play
in implementing and sustaining of the programme. The
rapid scale up did not allow for community dialogue and
community empowerment [31,32]. Unless these limita-
tions are addressed, the result may be continued low uti-
lization of HOMAPAKS, especially among the poorest
that are often most difficult to reach [7]. Furthermore, the
sustainability of DDs will remain a challenge as long as
there is little community commitment to support DDs.
While a desirable, participatory process in every village is
not compatible with rapid national scale-up – a balance
needs to be reached. This study implies that if HBM is to
succeed and be sustained, more investment should be
made in an iterative process of community consultation
and establishment of interventions that are well inte-
grated into government structures. This iterative process
would include localized studies to not only help under-
stand the local context, perceptions and construction of
local medical knowledge [33], but also detect concerns
emerging from the implementation experiences [34]. In
this context, qualitative methods have the potential to
identify effects of context, cultural values and local per-
ceptions on the service delivery and utilization [35,36].
Information from such studies will be useful in the design
of communication packages to optimize diffusion of
national drug policy and enhance community adoption
of new interventions such as HBM. Community sensitiza-
tion is also another vital input and should include inform-
ing the communities about the possibilities of resistance-
induced treatment failure, side effects and the need of
referral in case of no improvement. As evident from this
study much more powerful, locally appropriate behaviour
change communication needs to be implemented to
increase uptake and address misconceptions on a new
intervention like HBM [8].
Supporting DDs for sustainable good performance
The drug distributors did not feel well supervised, facili-
tated or recognized by the local government. The impor-
tance of recognition, training, supervision and incentives
for community volunteers have been highlighted in sev-
eral studies [37-39]. Although the HBM guidelines recom-
mended giving incentives to the DDs [4,5] this has not
been realized. Due to high level of unemployment, peo-
ple volunteer with hope that they will be remunerated
eventually [40]. But long-term pure voluntary work is
hard to sustain and in countries with already severely con-
strained health budgets, monetary incentives for an addi-
tional cadre of health workers may not be a realistic
option [41]. Still, the use of volunteers without any form
of incentives could be a liability not only to the sustaina-
bility of the intervention, but also to DD performance, as
motivational factors are a crucial component in the per-
formance equation [42]. This effectively means that a
strong community health programme requires a strong
health system, and innovative incentive programmes to
keep up the quality and motivation among community
volunteers. If well trained, facilitated and integrated into
the local health system, DDs could contribute substan-
tially to prompt and appropriate management of acute
febrile illness.
Methodological considerations
Like with most qualitative studies the magnitude of the
problems identified could not be established, such as use
of the HOMAPAKS in relation to other drugs and the
extent of referral. Another limitation was that the subject
was sensitive in case of some respondents such as DDs
and health workers who were reluctant to discuss weak-
nesses in the approach since they would share part of the
blame. By triangulating several qualitative methods with
different respondents, it was possible to identify and con-
firm pertinent issues. Observations complemented the
other findings and provided contextual information
which was useful in the analysis. Although there were no
serious contradictions between the different methods of
data collection, some categories of respondents were more
elaborate on some information than others. For instance
for DDs and health workers, the perception that
HOMAPAK is a light drug was a big concern, whereas the
caretakers themselves did not dwell on it so much.
Conclusion
This study has demonstrated that the community appreci-
ates the contribution of home based management of fever
(HBM). This is an important prerequisite in the strength-
ening of HBM. This achievement has been realized as a
result of the availability of drugs at the community level
through the services of DDs. If well trained, facilitated and
integrated into the local health system, DDs could con-
tribute substantially to prompt and appropriate manage-
ment of acute febrile illness. There is a need to
operationalize methods to address the perceptions of drug
efficacy and community expectations in systematic and
strong information/behaviour change communication to
increase uptake and use of drugs supplied by DDs, as well
as aspects of retention and performance of DDs. There is
also a need for an iterative approach whereby current
efforts are evaluated and improved over time which
requires a close link between policy and research [43]. In
this context, qualitative methods have the potential to
identify effects of context, cultural values and local per-
ceptions on the service delivery and utilization [35].Malaria Journal 2007, 6:11 http://www.malariajournal.com/content/6/1/11
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